Brief: Anebulo Pharmaceuticals Announces Intention To Voluntarily Delist From Nasdaq And Deregister With SEC
06/02/2026 14:01
Feb 6 (Reuters) - Anebulo Pharmaceuticals Inc ANEB.O: ANEBULO PHARMACEUTICALS ANNOUNCES INTENTION TO VOLUNTARILY DELIST FROM NASDAQ AND DEREGISTER WITH SEC ANEBULO PHARMACEUTICALS - STOCK TO TRADE PRIVATELY & ON OTC MARKET POST-DELISTING Source text: ID:nBw5ksG2Wa Further company coverage: ANEB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anebulo Pharmaceuticals
See all newsAdvisory: Dated alert on Anebulo Pharmaceuticals' voluntary delisting from Nasdaq withdrawn
Anebulo Pharmaceuticals Q2 net loss narrows
Brief: Anebulo Pharmaceuticals Announces Intention To Voluntarily Delist From Nasdaq And Deregister With SEC
Anebulo Pharmaceuticals posts Q1 net loss
Brief: Anebulo Pharmaceuticals Reports Fourth Quarter And Fiscal Year 2025 Financial Results